The concomitant utilization of oxycodone HCl with all cytochrome P450 3A4 inhibitors may possibly result in an increase in oxycodone plasma concentrations, which could boost or extend adverse reactions and could trigger perhaps deadly respiratory melancholy. In addition, discontinuation of a concomitantly utilised cytochrome P450 3A4 inducer may we